Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 115
- +6 vs. Q2 2022
- Portfolio value
- $3.44B
- +$257.8M (+8.1%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | COM | 90,748 | $2.24M | 0.1% | −479,336−84.1% | Reduced | History |
| PEARPear Therapeutics, Inc. | CLASS A COM | 900,548 | $1.84M | 0.1% | 00.0% | Unchanged | History |
| DRIODarioHealth Corp. | COM NEW | 327,869 | $1.52M | <0.1% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 290,051 | $859.0K | <0.1% | 00.0% | Unchanged | History |
| HYPRHyperfine, Inc. | COM CL A | 927,388 | $751.0K | <0.1% | −207,000−18.2% | Reduced | History |
| SONXSonendo, Inc. | COM | 612,204 | $655.0K | <0.1% | −36,301−5.6% | Reduced | History |
| PRVBProvention Bio, Inc. | COM | 110,728 | $498.0K | <0.1% | 00.0% | Unchanged | History |
| ICVXIcosavax, Inc. | COM | 93,591 | $296.0K | <0.1% | −949,259−91.0% | Reduced | History |
| MOTSMotus GI Holdings, Inc. | COM NEW | 90,027 | $221.0K | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | History |
| EQRx, Inc.26886C115 | *W EXP 12/17/202 | 250,000 | $205.0K | <0.1% | 00.0% | Unchanged | – |
| AGRXAgile Therapeutics Inc | COM NEW | 532,361 | $158.0K | <0.1% | 00.0% | Unchanged | History |
| CareMax, Inc.14171W111 | *W EXP 06/08/202 | 60,000 | $113.0K | <0.1% | 00.0% | Unchanged | – |
| NEPTFNeptune Wellness Solutions Inc. | COM NEW | 57,142 | $87.0K | <0.1% | 00.0% | Unchanged | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 166,666 | $31.0K | <0.1% | 00.0% | Unchanged | – |
| SRZNSurrozen, Inc. | COM | 6,017 | $12.0K | <0.1% | 00.0% | Unchanged | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| TCDATricida, Inc. | COM | $5.24M | – |
Sold out since Q2 2022 (9)
Positions held at the end of Q2 2022 that are gone from this filing.
| Security | Class | Shares in Q2 2022 | Value in Q2 2022 | % of portfolio in Q2 2022 | History |
|---|---|---|---|---|---|
| LLYEli Lilly & Co | Stock | 100,000 | $32.4M | 1.0% | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 172,991 | $25.2M | 0.8% | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 556,047 | $9.95M | 0.3% | History |
| PRVAPrivia Health Group, Inc. | COM | 273,423 | $7.96M | 0.3% | History |
| NUVBNuvation Bio Inc. | COM CL A | 1,769,701 | $5.73M | 0.2% | History |
| MGNXMacrogenics Inc | COM | 1,227,202 | $3.62M | 0.1% | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 1,052,445 | $2.62M | 0.1% | History |
| RACEFerrari N.V. | COM | 6,200 | $1.14M | <0.1% | History |
| ZYZymergen Inc. | COM | 883,332 | $1.09M | <0.1% | History |